New promising therapy for carefully selected PCa patients: TOOKAD (padeliporfin). The Light in the future of Focal therapy @F_Montorsi @GGandaglia @urosuardi @ale87nini @ezaffuto #prostatecancer #EAU18 #prostatecancer #siu_italia https://t.co/khxbILDStF
New promising therapy for carefully selected PCa patients: TOOKAD (padeliporfin). The Light in the future of Focal therapy @F_Montorsi @GGandaglia @urosuardi @ale87nini @ezaffuto #prostatecancer #EAU18 #prostatecancer #siu_italia https://t.co/khxbILDStF